Just did a little comparison to the previous quarter:Jan-Mar: Revenue US$235m, cash margin US$189mApr-Jun: Revenue US$337m (+43%), cash margin US$292m (+54%)Looks alright to me
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution